Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

TDP-43 Proteinopathies trial results

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Nova Southeastern University Davie, Florida, United States
View all 25 locations
Conditions
ALS, Amyotrophic Lateral Sclerosis, Bulbar Palsy, Progressive, +21 more
Locations
  • Loma Linda University Health Loma Linda, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Northwestern University Chicago, Illinois, United States
View all 18 locations
Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Haukeland University Hospital, Department of Neurology Bergen, Norway
  • Nordland Hospital Trust, Department of Neurology Bodø, Norway
  • Vestre Viken Hospital Trust, Department of Neurology Drammen, Norway
  • Førde Hospital Trust, Department of Neurology Førde, Norway
View all 17 locations

NCT06735014

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Northwestern University Evanston, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States